Clinical approaches to minimize rash associated with EGFR inhibitors.
K Oishi - Oncology Nursing Forum, 2008 - search.ebscohost.com
Abstract Purpose/Objectives: To present a systematic approach for managing the skin rash
associated with epidermal growth factor receptor (EGFR)-targeted therapies. Data Sources …
associated with epidermal growth factor receptor (EGFR)-targeted therapies. Data Sources …
Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer
A Kotsakis, V Georgoulias - Expert Opinion on Pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: The management of non-small-cell lung cancer (NSCLC) has
undergone a paradigm shift in the last decade, with the survival advantage demonstrated by …
undergone a paradigm shift in the last decade, with the survival advantage demonstrated by …
Enhanced antitumor activity of cetuximab in combination with the Jak inhibitor CYT387 against non-small-cell lung cancer with various genotypes
Y Hu, XZ Dong, X Liu, P Liu, YB Chen - Molecular pharmaceutics, 2016 - ACS Publications
Cetuximab, an epidermal growth factor receptor (EGFR) inhibitor, is effective in the treatment
of non-small-cell lung cancers (NSCLCs). However, resistance to EGFR inhibitors limits its …
of non-small-cell lung cancers (NSCLCs). However, resistance to EGFR inhibitors limits its …
EGF ligand fused to truncated Pseudomonas aeruginosa exotoxin A specifically targets and inhibits EGFR‑positive cancer cells
SM Hashimi, B Grant, N Alqurashi… - Oncology …, 2018 - spandidos-publications.com
Cancer cells have been known to overexpress the epidermal growth factor receptor (EGFR)
and hence relevant multiple‑targeted therapies have been developed, with a recent clinical …
and hence relevant multiple‑targeted therapies have been developed, with a recent clinical …
Evidence-based principles in pathology: existing problem areas and the development of “quality” practice patterns
MR Wick, AM Marchevsky - Archives of Pathology & …, 2011 - meridian.allenpress.com
Context.—Contrary to the intuitive impressions of many pathologists, several areas exist in
laboratory medicine where evidence-based medicine (EBM) principles are not applied …
laboratory medicine where evidence-based medicine (EBM) principles are not applied …
Clinically Relevant Radioactive Dose Formulation of 177Lu‐Labeled Cetuximab‐Fab Fragment for Potential Use in Cancer Theranostics
The goal of this study is to generate Fab fragment of cetuximab, a chimeric monoclonal
antibody targeting epidermal growth factor receptor (EGFR) on the surface of cancer cells …
antibody targeting epidermal growth factor receptor (EGFR) on the surface of cancer cells …
Evidence-based principles and practices in pathology: selected problem areas
MR Wick, TD Bourne, JW Patterson, SE Mills - Seminars in Diagnostic …, 2005 - Elsevier
Contrary to the intuitive impression of most pathologists, there are still many areas in
laboratory medicine where evidence-based medicine (EBM) principles are not applied …
laboratory medicine where evidence-based medicine (EBM) principles are not applied …